1. Home
  2. REPL vs CMP Comparison

REPL vs CMP Comparison

Compare REPL & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REPL
  • CMP
  • Stock Information
  • Founded
  • REPL 2015
  • CMP 1993
  • Country
  • REPL United States
  • CMP United States
  • Employees
  • REPL 479
  • CMP N/A
  • Industry
  • REPL Biotechnology: Pharmaceutical Preparations
  • CMP Other Metals and Minerals
  • Sector
  • REPL Health Care
  • CMP Basic Materials
  • Exchange
  • REPL Nasdaq
  • CMP Nasdaq
  • Market Cap
  • REPL 239.0M
  • CMP 836.2M
  • IPO Year
  • REPL 2018
  • CMP 2003
  • Fundamental
  • Price
  • REPL $3.15
  • CMP $20.37
  • Analyst Decision
  • REPL Buy
  • CMP Buy
  • Analyst Count
  • REPL 10
  • CMP 3
  • Target Price
  • REPL $8.25
  • CMP $19.00
  • AVG Volume (30 Days)
  • REPL 9.2M
  • CMP 680.4K
  • Earning Date
  • REPL 08-07-2025
  • CMP 09-16-2025
  • Dividend Yield
  • REPL N/A
  • CMP N/A
  • EPS Growth
  • REPL N/A
  • CMP N/A
  • EPS
  • REPL N/A
  • CMP N/A
  • Revenue
  • REPL N/A
  • CMP $1,213,500,000.00
  • Revenue This Year
  • REPL N/A
  • CMP $11.60
  • Revenue Next Year
  • REPL N/A
  • CMP $2.33
  • P/E Ratio
  • REPL N/A
  • CMP N/A
  • Revenue Growth
  • REPL N/A
  • CMP 5.81
  • 52 Week Low
  • REPL $2.68
  • CMP $7.51
  • 52 Week High
  • REPL $17.00
  • CMP $22.69
  • Technical
  • Relative Strength Index (RSI)
  • REPL 24.82
  • CMP 45.73
  • Support Level
  • REPL $2.68
  • CMP $20.31
  • Resistance Level
  • REPL $3.85
  • CMP $21.72
  • Average True Range (ATR)
  • REPL 0.80
  • CMP 0.68
  • MACD
  • REPL -1.03
  • CMP -0.24
  • Stochastic Oscillator
  • REPL 4.45
  • CMP 2.52

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

About CMP Compass Minerals Intl Inc

Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.

Share on Social Networks: